pharmaphorum

OCTOBER 7, 2021

Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. “We expect to manufacture our COVID-19 vaccine as well as additional products within our mRNA vaccine portfolio at this facility.”

Vaccination 98

Vaccination Vaccine Manufacturing Packaging 98

Fossil Remedies

OCTOBER 23, 2019

Start your pharmaceutical distribution company today. What does a pharma distribution company do? It can be described as the link between the manufacturing company and the retail pharmacy or directly the users. You can begin with a manufacturing unit. Evaluate the business options thoroughly.

Manufacturing 67

Manufacturing Branding Pharma Companies Pharma Production 67

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. But what steps can the smaller companies at the cutting edge take to make them acquisition-ready and maximise their value during this process?

Compliance 119

Compliance Regulation Manufacturing Licensing 119

pharmaphorum

SEPTEMBER 29, 2020

For example, under a traditional pharma/biotech collaboration and licensing model, a biotech partner may have primary responsibility for significant elements of research and early product development, and the pharma partner may lead the majority of later stage development, as well as post-approval commercial manufacture and supply.

Research 132

Research Gene Editing Development Gene 132

pharmaphorum

JANUARY 20, 2022

The mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma companies join forces.

Allergies 72

Allergies Marketing Production Manufacturing 72

pharmaphorum

SEPTEMBER 20, 2021

For the pharma industry, the pandemic’s changes were both abrupt and industry-altering, requiring companies to rapidly adapt their approaches to drug development and commercialisation. It also led to changes in how we manufacturer, market and ship medications.

Sales 98

Sales Marketing Pharma Companies Licensing 98

Fossil Remedies

AUGUST 21, 2019

A pharma franchise business model is when a company permits to sell the products by its name. It is an agreement between a franchiser which is typically a pharma manufacturing (or marketing) company where a franchisee is an individual entrepreneur or a small company that buys the license.

Pharma Companies 40

Pharma Companies Production Licensing Licensing 40

pharmaphorum

DECEMBER 16, 2022

Of significant interest to the pharma industry are the suggestions in the draft text that money granted for research on infectious diseases could include specifications on how eventual products could be marketed. In response, some companies, such as Pfizer , have made commitments to sell products to the countries at non-profit prices.

Vaccination 96

Vaccination Vaccine Production Licensing 96

pharmaphorum

NOVEMBER 12, 2020

The mid-sized pharma group has also signed a collaboration with Florida, US-based Lacerta Therapeutics , adding more AAV capsids – well established as a staple for delivering gene therapy sequences – as well as another gene therapy candidate.

Gene Therapy 52

Gene Therapy Gene Manufacturing Contract Manufacturing 52

pharmaphorum

MARCH 26, 2021

The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. Andrew is also an expert on GDPR.

Production 119

Production Medicine Marketing Regulation 119

Fossil Remedies

SEPTEMBER 20, 2019

It is important to know about the license requirements, compliance requirements and other aspects well. Fossil Remedies is leading manufacturers and marketers of Pharma Products who hold rich expertise as PCD Pharma Franchise Company in Ahmedabad, Gujarat, India.

Pharma Production 75

Pharma Production Production Marketing Compliance 75

pharmaphorum

JANUARY 7, 2021

The California-based company has signed a non-exclusive license with Pfizer to supply its 89Zr CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer patients.

Immune Response 53

Immune Response Doctors Doctor Pharma Companies 53

pharmaphorum

DECEMBER 7, 2020

Having worked all around the world to supply medicines to developing markets, Dr Zulf Masters understands the biggest barrier for a pharma company entering these regions is a lack of understanding of their complexities. Developing market specialist Dr Zulf Masters OBE takes us through the nuances of being successful in this region.

Marketing 109

Marketing Regulation Production Medicine 109

pharmaphorum

AUGUST 25, 2021

It’s now globally accessible due to Gilead’s work with a network of generic manufacturers and their ability to sign licensing agreements just days after the US FDA registered its authorisation. We went back to what we do best … we engaged our network of companies. It’s not a coincidence that we now have over 2.3

Marketing 52

Marketing Licensing Licensing Manufacturing 52

XTalks

SEPTEMBER 5, 2023

Investigation of the possibility of VAED is crucial during clinical trials for decision-making on vaccine licensing by regulatory agencies. To address cultural considerations, it is essential that pharma companies work together with healthcare providers to promote trust in vaccines.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

Creogenic Pharma

FEBRUARY 17, 2021

Thus, Creogenic Pharma is a leading and reliable PCD Pharma Franchise Company in TamilNadu with caliber-rich medications. Creogenic Pharma is currently India’s best Pharma PCD Franchise firm that manufactures, advertises, and supplies a wide range of high-quality medications and healthcare solutions.

Production 52

Production Sales Pharma Companies Marketing 52

pharmaphorum

APRIL 19, 2022

RudaCure is a four-year-old biotech company based in the South Korea, focusing on ocular disease and chronic pain with a pair of potentially first-in-class drugs. The company recently raised $16.5 Currently it’s dominated by several offerings from major manufacturers. Everyone in our team is very valuable,” he said.

Marketing 52

Marketing Clinical Trials Clinical Trials Development 52

pharmaphorum

MAY 21, 2021

It builds on the company’s four partnership projects: two with the generics and biosimilars firm Hikma, one with US biotech Inhibrix and another with an unnamed biosimilars partner. An AIM listing will help the company become established and bring it to the attention of investors and the wider public, said Howell. “We

Insulin 52

Insulin Drugs Production Marketing 52

Pharma Business Blog

MARCH 16, 2022

Happy to share the following Article of Chemie Pharma Innovation with you (German only): [link]. Dr. Sandra Ragaz , Partner Leader Pharma & Life Science VAT Switzerland Tel: +41 58 792 44 69 sandra.ragaz@pwc.ch. Der Beitrag The Pharma Gamechanger erschien zuerst auf Welcome. Have a pleasant reading.

Life Science 52

Life Science Licensing Licensing Pharma Companies 52

Advarra

JULY 19, 2022

Also consider quality agreements for key vendors, such as contract development and manufacturing organizations (CDMO) and CROs. Do you search for similar products, and use existing IND criteria requirements against the latest manufacturing guidance docs? A: Working in a pharmaceutical company is the best way to learn this.

Packaging 52

Packaging Packaging Drugs Containment 52

Pharmaceutical Technology

MAY 26, 2023

Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. The British company’s expanded facilities boasts of 11 suites, including two class B filling suites with class A filling cabinets, warehousing and quality control laboratory capability.

DNA 130

DNA Manufacturing Gene Gene Therapy 130

pharmaphorum

MAY 20, 2022

In one of the first moves by a member of ATOM, Novartis has agreed to license rights to its tyrosine kinase inhibitor drug nilotinib – sold as Tasigna as a leukaemia treatment – to the UN-backed Medicines Patent Pool (MPP).

Drugs 111

Drugs Medicine Licensing Licensing 111

Pharma Marketing Network

OCTOBER 27, 2020

So a doctor that’s licensed stay only in the state of New York would be able to practice across the entire counties using Telemedicine. First it has a black box warning it’s contraindicated in things like COPD and asthma because powdered aerosols make you cough is a big problem. Don ( PMN): Ah okay.

Insulin 52

Insulin Marketing Doctors Doctor 52

Pharma Marketing Network

OCTOBER 27, 2020

So a doctor that’s licensed stay only in the state of New York would be able to practice across the entire counties using Telemedicine. First it has a black box warning it’s contraindicated in things like COPD and asthma because powdered aerosols make you cough is a big problem. Don ( PMN): Ah okay.

Insulin 52

Insulin Doctors Doctor Marketing 52

pharmaphorum

SEPTEMBER 8, 2022

Big pharma has already noted its interest in the area, as seen in Novartis’ investments. Last year, the company signed two deals in quick succession, which saw it form a licensing deal worth $1.3 billion with Artios Pharma and with iTheranostics for a number of diagnostic radiopharmaceuticals. Different methods.

Manufacturing 105

Manufacturing Development Antibody Drugs 105

pharmaphorum

FEBRUARY 12, 2021

Sandoz will eventually transfer manufacturing of Zinnat to its own network, but in the meantime GSK has agreed to continue to supply the drug for the next four years. It shut down antibacterial and antiviral research at its Novartis Institutes for Biomedical Research campus in California, and put its drug candidates out to license.

Drugs 111

Drugs Sales Marketing Pharma Companies 111

XTalks

DECEMBER 29, 2022

Vertex is planning to submit a Biologics License Application (BLA) by the end of the first quarter of 2023 and the company says it is also on track to submit exa-cel to UK and European Union (EU) regulators by the end of the year. 3. Manufacturing & Supply Chain: Addressing Drug Shortages. 4. Social Media Marketing.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Exelead was part of that success, helping to manufacture vaccine precursors for the Pfizer/BioNTech shot Comirnaty. The unit contributed almost €3.4

Vaccination 98

Vaccination Vaccine Manufacturing Life Science 98

XTalks

MARCH 22, 2023

While not a record-breaking deal at $17 billion, the buyout strengthened Pfizer’s injectables business unit with the company reporting an 11 percent increase in revenue the following year. Controlling for inflation , this represents a 53 percent increase in investment in pharma R&D in the past two decades.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

DECEMBER 13, 2023

Now, let’s delve into the list of the top ten fastest growing biotech companies in 2023, ranked by their compound annual growth rate (CAGR). These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times. In the third quarter of 2023, the company’s revenue surged to $63.7

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

SEPTEMBER 22, 2021

Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies of for not agreeing to waive their intellectual property rights and share the technology behind them. All will be made in Pfizer’s US manufacturing facilities. billion doses administered worldwide, just 0.3%

Vaccination 105

Vaccination Vaccine Manufacturing Licensing 105

Pharmaceutical Technology

MARCH 16, 2023

With restricted access and reduced prescription of puberty blockers and hormone therapies, the impact on pharmaceutical companies manufacturing these therapies also remains unclear. One of the reasons why organisations, including pharma companies, do not enter this debate is because these drugs are used off label, says Horowicz.

Drugs 360

Drugs Hormones Trials FDA Approval 360

World of DTC Marketing

APRIL 12, 2021

A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. Can patients really be confident in pharma supply chains? Why would a pharma company take risks like these?

Generic Drugs 187

Generic Drugs Manufacturing Drugs Production 187

pharmaphorum

JUNE 11, 2021

The Philadelphia-based company said it had taken the decision to go down the biologics license application (BLA) route for Covaxin based on FDA feedback to the EUA data package it had submitted to the agency. Bharat has also reported data suggesting the shot is effective against the beta (B.1.351) 1.351) variant.

Vaccination 83

Vaccination Vaccine Clinical Trials Clinical Trials 83

XTalks

MAY 29, 2024

The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccination 52

pharmaphorum

DECEMBER 21, 2020

While Moderna blazed its investment trail and tried to find ways to make sure its mRNA vaccines did not produce dangerous immune reactions, a small biotech called BioNTech had licensed in the technology from Kariko and Weissman. You can manufacture mRNA vaccine overnight and still it is stable,” said Kromayer.

Vaccination 111

Vaccination Vaccine Doctor Doctors 111

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. As a result, multiple vaccines, including Pfizer /BioNTech’s mRNA vaccine, Comirnaty, were licensed for use within a year of development beginning.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234